Executive Oncology Account Manager

About Summit:

Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people.

Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence.

Summit’s team is inspired to touch and help change lives through Summit’s clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including:

Non-small Cell Lung Cancer (NSCLC)

HARMONi:
Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI.

HARMONi-3:
Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC.

HARMONi-7:
Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC.

HARMONi-GI3:
Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy.

Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland.

Location:
Denver, CO (Field Based)

Overview of Role:

The Executive Oncology Account Manager (OAM) will be responsible for driving the successful launch and commercialization of ivonescimab within an assigned U.S. territory. Reporting to a Regional Business Director (RBD), this individual contributor role is accountable for developing and executing territory-level business plans, building strong customer relationships, and achieving sales objectives in alignment with national and regional commercial strategies.

The Executive Oncology Account Manager will engage oncology customers across community practices, academic centers, integrated delivery networks, and other key accounts to support appropriate product education and access. This role will collaborate closely with cross-functional partners, including Marketing, Market Access, Medical Affairs, Commercial Operations, and regional leadership, to deliver a best-in-class customer experience and support business performance.

Role and Responsibilities:

• Develop and execute territory business plans to achieve sales objectives, market share goals, and product launch priorities within the assigned geography.
• Build and maintain strong relationships with oncology healthcare professionals, key opinion leaders, practice administrators, and other relevant stakeholders.
• Effectively communicate product information, clinical value, and approved promotional messaging in accordance with company policies and compliance standards.
• Analyze territory performance, customer needs, market trends, and competitive dynamics to identify opportunities and adjust business plans accordingly.
• Partner with the Regional Business Director to align territory priorities with regional strategies, performance expectations, and launch execution plans.
• Coll…